The Centers for Disease Control and Prevention’s vaccine tracker is showing that 189 million Americans are fully vaccinated, equal to about 57% of the overall population, still below the 70% experts say is needed to rein in the spread. Some 10.5 million Americans have received a booster dose, the data shows.
More than two-thirds of Americans over the age of 12, however, are now fully vaccinated, according to the CDC , and 77.1% of that population has had at least one vaccine dose.
Dr. Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases, said Sunday that it is “really unfortunate” that Gov. Greg Abbott has moved to ban vaccine mandates in the state of Texas, the AP reported.
Speaking on “Fox News Sunday,” Fauci said that the Republican governor’s decision to block businesses from requiring inoculations would damage public health, since vaccines are the “most effective means” to stop the spread of COVID-19.
Some 1,002 people died of COVID-19 in a single day, breaking the previous record of 999 deaths set Friday. The vast country of 146 million people counted 33,208 new cases.
England is planning to push for teenagers to get their shots, after slower-than-expected take-up has left the rate below 10% in over a third of the main local authorities in the country, the Guardian reported. The U.K. recorded 45,140 new cases on Sunday, the highest jump in positive cases since mid-July, the paper reported.
The European Union has exported more than 1 billion vaccine doses since December 2020, making the bloc the biggest vaccine exporter, European Commission head Ursula von der Leyen said on Monday, as Reuters reported Vaccines have gone to more than 150 countries, and the EU has exported as many doses as it had distributed to its own population, von der Leyen added in a statement.
The EU is working with the administration of President Joe Biden to achieve the goal of getting 70% of the world’s population vaccinated by next September.
In medical news, two doses of either the vaccine made by Pfizer and partner BioNTech or AstraZeneca /zigman2/quotes/200304487/composite AZN +4.20% /zigman2/quotes/203048482/delayed UK:AZN +4.19% in partnership with Oxford University provided a similar level of protection to prior natural infection when the delta variant was dominant, the U.K. Office of National Statistics said Monday .
Vaccination significantly reduced the risk of people testing positive during both the alpha-dominant period and the delta-dominant period, but effectiveness was reduced in the delta-dominant period compared with the alpha-dominant period. The ONS added that two doses of either vaccine provided significantly greater protection than one dose across all analyses.
And French biotech Valneva /zigman2/quotes/226552993/composite VALN -2.99% /zigman2/quotes/202377434/delayed FR:VLA -4.01% said its vaccine candidate outperformed AstraZeneca’s in a trial. The Phase 3 trial involved 4,012 people and showed a significantly more favorable tolerability profile. Valneva said its vaccine produced more neutralized antibodies and there was a complete absence of any severe COVID-19 cases.
The global tally for the coronavirus-borne illness climbed above 240.8 million on Monday, while the death toll edged above 4.9 million, according to data aggregated by Johns Hopkins University .
The U.S. continues to lead the world with a total of 44.9 million cases and 724,502 deaths.
India is second by cases after the U.S. at 34 million and has suffered 452,290 deaths. Brazil has the second highest death toll at 603,282 and 21.6 million cases.
In Europe, Russia has most fatalities at 220,323, followed by the U.K. at 138,997.
China, where the virus was first discovered late in 2019, has had 108,927 confirmed cases and 4,809 deaths, according to its official numbers, which are widely held to be massively underreported.